






































,0.001).  There  were  no  overall  differences  between  groups  in  PF  change.  Among  patients  with 
impaired  baseline  PF,  however,  OX  was  significantly  less  effective  than  NA  and  PRT  was 
significantly better than NA. All treatments led to increases in protein intake and performance; NA 
and PRT also increased caloric intake. The institutional costs per subject in this trial were $983 for 
NA,  $3772  for OX,  and  $3189  for  PRT.  At  a  community‐based  level  of  intensity,  the  institutional 
costs  per  QALY  were  $45,000  (range:  $42,000–$64,000)  for  NA,  $147,000  (range:  $147,000–
$163,000) for OX, and $31,000 (range: $21,000–$44,000) for PRT.  






























































































































































































































































































































































































































































79 persons screened in-person
24 ineligible
























































































NA (N - 18) ox (N - 16) PRT (N - 16)
Female gender (n) 3 (17%) 5 (3 I%) 7 (44%)
Age (y) 43.6 (37.3, 48.6) 40.8 (36.2, 45.2) 43.2 (38.4, 45.9)
Taking any ART (n) 15 (83%) 14 (88%) 12 (75%)
Taking HAART (n) 13 (72%) 14 (88%) II (69%)
Hepatitis or other AIDS-defining 6 (35%) 6 (38%) 4 (27%)
condition (n)
Has hepatitis B (n) 2 (14%) 2 (14%) 2 (13%)








HIV RNA (Iog,JmL) 3.2 (2.3, 3.9) 3.2 (2.3, 4.0) 3.2 (2.3, 4.4)
Energy intake (kcal/d) 2705 (2296, 3594) 2285 (1605, 3262) 2623 (1848, 366 I)
Protein intake (gld) 108.0 (83.0, 131.8) 96.9 (60.6, 115.5) 109.9 (75.3, 131.6)







45.2 (35.4, 52. I)
110.4 (96.8, IJJ.4)
PF' 86 (72, 100) 89 (72, 100) 89 (69, 94)
Initial PF = 100 (n) 5 (28%) 5 (3 I%) 3 (19%)
N(%), median, and IQR are shown.
·Measured on l~tOO scale, with 100 representing best functioning.







60X Venus 6NA 6PRT 6PRT Venus
ANA AOX .1.0X (With Baseline .1.PRT Versus ANA (With Baseline
Acm Mm Versus .1.NA Interaetion) Arm ANA loteraetion)
Muscle area (COIl) 2.0 (5.3) 6.9 (10.0)'" P = 0.09 P = 0.24 5.3 (9.0)· P = 0.26 P = 0.63
PF, 6.9 (20.5) -1.0 (18.8) P = 0.20 p,. 0.005 10.4 (14.7)+ P = 0.59 P < 0.001§
8MI (kg/OIl) 0.43 (0.90) 0.35 (1.25) P = 0.84 P = 0.62 0.39 (0.94) P = 0.93 P = 0.79
FFM (kg) 0.90 (1.62)· 1.72 (3.00)· P=0.31 P = 0.55 1.17 (2.24) P = 0.75 P= 0.17
Energy intake (kealfd) 542 (974)- 403 (1078) P = 0.68 P < O.OOI§ 724 (844)t P = 0.59 p < 0.001
Energy intake (kcal!kg/d) 8.0 (14.3)- 7.0 (19.6) p = 0.86 P< 0.001§ 13.3 (14.4)t P = 0.35 P = 0.04
Protein intake (gfd) 38.6 (33.5)t 32.3 (36.0)t P - 0.59 P < 0.001§ 40.8 (30.7)t P - 0.85 P - 0.005
Protein intake (glkg/d) 0.60 (0.53)t 0.57 (0.66)t P = 0.87 P < O.OOI§ 0.73 (0.54)t P = 0.54 p", 0.07
Leg press (psi) 34 (158) 48 (108) P = 0.78 P = 0.57 158 (132)t P = 0.013 P = 0.35
Chest press (psi) -3.3 (11.4) 3.8 (9.0) P= 0.12 p .. 0.96 22.0 (16.3)t P < 0.001 P - 0.005
Kncc extension (psi) 0.79 (8.5) 2.6 (7.8) P = 0.62 p= 0.10 11.0 (11.6)t P= 0.15 P = 0.76
Scated row (psi) 3.2 (13.4) 6.4 (9.2)- P = 0.50 P = 0.70 16.6 (16.5)t P = 0.007 P = 0.02§
CYBEX flexion (N-m) -0.83 (15.3) 3.36 (13.41) P = 0.43 p .. 0.08 9.07 (13.7)+ P = 0.06 P = 0.32
CYBEX extension (N-m) -1.08 (27.2) -0.29 (19.6) P = 0.93 p= 0.003 12.6 (21.4)· P= 0.11 P = 0.03
Curl-ups (reps) 3.0 (4.7)+ 5.6 (7.4)- P = 0.35 p= 0.51 83 (9.0)1 P = 0.06 P = 0.94
Six-minute walk (yd) 277 (245)- 242 (268)· p,., 0.74 P= 0.03 211 (l88)t P-0.51 p .. 0.004§
Chair stands (s) -2.4 (2.6)t -2.9 (2.5)t P = 0.64 p= 0.14 - 3.7 (3.0)t P=0.21 P = 0.007§
Statistically significant between-group changes are shown in bold.
• p < 0.05: tP < 0.01.
*Mcasured on 1-100 scale. with 100 representing best functioning.
§Statislically significant (P < 0.05) interaction between the baseline value and the response to treatment
FFM indicates fat-free mass; N-m. N~'wton-mcteN; reps. repetitions.
Table 3: Comparison of Institutional Costs per Subject 
 
Institutional Study Cost Total Study Cost TOlal rCM Cost Change in QALYs rCM Cost/QALY (Range)
NA S766.34 5983.36 5595.75 0.001 (P = 0.82) S45.243 (545.243-S64.335)
OX versus NA $3772.16 $3772.16 $3384.55 0.022 (P- 0.61) $146.709 ($146.709-$63.163)
PRT versus NA $1636.00 S3189.38 $2987.38 0.045 (P = 0.20) S30,708 ($21.1 52-S355 1)
